Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseases

Inhaled glucocorticoids acting via the glucocorticoid receptor are a mainstay treatment option for individuals with asthma. There is a consensus that the remedial actions of inhaled glucocorticoids are due to their ability to suppress inflammation by modulating gene expression. While inhaled glucoco...

Descripción completa

Detalles Bibliográficos
Autores principales: Giembycz, Mark A., Newton, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335793/
https://www.ncbi.nlm.nih.gov/pubmed/25750734
http://dx.doi.org/10.12703/P7-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335793/
https://www.ncbi.nlm.nih.gov/pubmed/25750734
http://dx.doi.org/10.12703/P7-16

Ejemplares similares